Ropes & Gray advised Ginkgo Bioworks, a horizontal platform for cell programming, in an agreement to acquire biotechnology company Zymergen in an all-stock transaction that values Zymergen at approximately $300 million.
Under the agreement, which has been unanimously approved by the board of directors of both companies, Zymergen stockholders will receive a fixed exchange ratio of 0.9179 Ginkgo shares for each Zymergen share, representing a 5.25% pro forma ownership of Ginkgo following the transaction that was announced on July 25.
The Ropes & Gray team was led by mergers & acquisitions partner Suni Sreepada, mergers & acquisitions partner Marko Zatylny and included IP transactions partner Amanda Austin, employment & benefits partners Renata Ferrari, Richard Kidd and Megan Bisk, tax partner Pam Glazier, litigation & enforcement partners Lisa Bebchick, Mike McFalls, Martin Crisp, Ama Adams and Ruchit Patel, life sciences regulatory & compliance partner Kellie Combs, real estate partner Peter Alpert, data, privacy & cybersecurity partner Ed McNicholas, IP transactions partner Melissa Rones, business restructuring partner Andrew Devore, private equity partner Milap Patel, health care counsel Leslie Thornton, life sciences regulatory & compliance counsel Beth Weinman, litigation & enforcement counsel Deidre Johnson, Alison McLaughlin and Joseph Rafferty, real estate counsel Laurie Nelson and private equity counsel James Kaplan.
Attorneys
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.